Drugs / Rabies vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00694460 | Aug 2002 → Aug 2004 | Japanese encephalitis, rabies | Novartis | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rabies vaccine | “The rabies vaccine PCECV and Japanese encephalitis vaccine are safe and immunogenic when administered concomitantly to toddlers.” NCT00694460 ↗ |
| Known as | PCECV | “Rabies vaccination with PCECV did not interfere with the antibody response to Japanese encephalitis vaccine.” NCT00694460 ↗ |
| Modality | Vaccine | “rabies vaccine PCECV” NCT00694460 ↗ |
| Route | Intramuscular | “purified chick embryo cell rabies vaccine 1.0 mL intramuscularly” NCT00694460 ↗ |